Journal ArticleOPEN ACCESS

Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab-induced arthritis by methylprednisolone, baricitinib, and remdesivir

Clinical Case Reports (2021) 9(7)
DOI: 10.1002/ccr3.4459
3Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

COVID-19 in cancer patients on immunosuppressive agents for the treatment of immune-related adverse events of immune checkpoint inhibitors can rapidly deteriorate. The combination therapy with methylprednisolone, baricitinib, and remdesivir may be effective for critical COVID-19, and further clinical trials are warranted.

Author supplied keywords

Cite

CITATION STYLE

APA

Oda, N., Miyoshi, K., Morichika, D., Beika, Y., Taki, T., Mitani, R., … Takata, I. (2021). Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab-induced arthritis by methylprednisolone, baricitinib, and remdesivir. Clinical Case Reports, 9(7). https://doi.org/10.1002/ccr3.4459

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free